Nasdaq
$1.07▲ 0.00%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $55.5MShares out 51.9M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
4- 8.12After-hours26.08.13 06:02S-8Offering#●●●#●●●
TALPHERA, INC.
On August 12, 2026, Talphera, Inc. filed a Form S-8 registration statement to register an additional 4.1 million shares of common stock for its equity compensation plans. This includes 4,000,000 shares for the 2020 Equity Incentive Plan and 100,000 shares for the 2011 Employee Stock Purchase Plan. This issuance represents equity dilution intended for employee compensation purposes.…more
$1.07+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 8.12After-hours26.08.13 05:1110-QEarnings
TALPHERA, INC.
Talphera, Inc. has filed its 10-Q quarterly report for the period ending June 30, 2026. The company is focused on managing operating costs and reducing cash burn, with its ability to continue as a going concern dependent on securing additional financing. As of August 5, 2026, the company had 51,905,796 shares of common stock outstanding.…more
$1.07+0.00%vs prev closeView filingShare - 8.12After-hours26.08.13 05:088-KKey event
TALPHERA, INC.
Talphera reported a net loss of $4.3 million ($0.06 per share) for Q2 2026, with cash and investments totaling $17.1 million. The NEPHRO CRRT clinical study for Niyad has reached 75% enrollment and is on track for completion this year, supported by the inclusion of nafamostat in the 2026 KDIGO guidelines.…more
$1.07+0.00%vs prev closeView filingShare
3 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswireNo news collected yet. New articles will appear here.